World Omni Auto Receivables Trust 2022-D has filed an update regarding its asset-backed securities. The filing, submitted on October 29, 2026, is significant as it highlights the trust's ongoing operations and compliance within the asset-backed securities sector. This update is crucial for investors and stakeholders, as it provides insights into the trust's performance and the broader market dynamics.
World Omni Auto Receivables Trust 2022-D, classified under the SIC code 6189, operates in the asset-backed securities industry. The trust is linked to World Omni Financial Corp., which serves as the primary loan servicer. The trust's recent filings include various forms, with the most recent being the ABS-EE, filed on October 29, 2026, following a series of 10-D filings throughout the year.
The latest filing states that the trust has submitted an Asset Data File and an Asset Related Document in accordance with SEC regulations. These documents are essential for maintaining transparency and providing detailed information about the trust's underlying assets, primarily auto loans. The filing indicates that the reporting period for this update covers from September 1, 2026, to September 30, 2026.
This filing may impact various stakeholders, including investors, analysts, and other firms in the asset-backed securities market. By providing detailed asset data, the trust aims to enhance investor confidence and maintain a competitive edge within the industry. The trust's commitment to transparency could influence how investors perceive risk and opportunity in similar asset-backed securities.
Looking ahead, the filing does not specify what happens next, leaving some uncertainty about future actions or additional disclosures from the trust. However, the ongoing updates and compliance efforts suggest that the trust will continue to engage with its stakeholders and the market.
Read Next
Georgia Banking Co Inc files prospectus for share resale
HSBC USA Inc. Offers New Autocallable Income Barrier Notes
HSBC USA Inc. launches Autocallable Contingent Income Notes
BofA Finance files pricing supplement for new income notes
Inmune Bio secures $4.5 million through securities agreement
BofA Finance LLC Files Pricing Supplement for $600,000 Notes






